Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Raising awareness as new Psychoactive Substances Act about to come into force

When the Psychoactive Substances Act 2016 comes into force on 6 April 2016 it will become an offence to produce or supply any psychoactive substance (excluding nicotine, alcohol, caffeine, medicines and controlled drugs). The main aim of the act is to prohibit and disrupt the production and supply of novel psychoactive substances (NPS, known as ‘legal highs’); primarily by shutting down high street vendors that currently trade in them. It is hoped that this will help to protect people from the risks posed by these untested, unknown and potential harmful substances, which may cause a variety of physical and mental health problems.

Although police forces are offering the opportunity to surrender stocks before this bill becomes law, there remain concerns that NPS may be sold cheaply as outlets try to shift their stock before they become illegal. Hopefully this will not be the case and we won’t see a flood of NPS on to the streets.

However, the pharmacy profession has an invaluable role to play in helping to raise awareness. In particular, community pharmacy teams (especially those offering needle exchange) should take the opportunity to offer harm reduction advice and signpost to specialist services to help make sure people know where they can get support with their substance misuse.

Roz Gittins

Lead clinical pharmacist (south west and mental health)


Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20200865

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.